Featured Research

from universities, journals, and other organizations

Obesity associated with longer hospital stays, higher costs in total knee replacement patients

Date:
May 14, 2014
Source:
American Academy of Orthopaedic Surgeons
Summary:
Obesity is associated with longer hospital stays and higher costs in total knee replacement patients, independent of whether or not the patient has an obesity-related disease or condition (comorbidity), according to a new study. More than half of TKR patients have a body mass index (BMI) within the obesity range (greater than 30 kg/mē), which has been linked to a higher risk for related comorbidities such as diabetes, hypertension, osteoarthritis; and in some studies, to higher medical costs and longer hospital stays.

Obesity is associated with longer hospital stays and higher costs in total knee replacement (TKR) patients, independent of whether or not the patient has an obesity-related disease or condition (comorbidity), according to a new study published in the Journal of Bone and Joint Surgery(JBJS).

More than half of TKR patients have a body mass index (BMI) within the obesity range (greater than 30 kg/mē), which has been linked to a higher risk for related comorbidities such as diabetes, hypertension, osteoarthritis; and in some studies, to higher medical costs and longer hospital stays. However, research has been inconclusive as to whether the higher related medical costs in obese TKR patients are directly due to a higher BMI or related comorbidities.

In the JBJS study, researchers reviewed the BMI, comorbidities, complications, outcomes and cost of care of 8,129 patients who had undergone 6,475 primary TKRs and 1,654 revision TKRs at a major medical center between Jan. 1, 2000 and Sept. 30, 2008. The median patient age was 68. Fifty-seven percent of the patients who underwent primary TKR and 53 percent who underwent revision TKR were female. The mean patient BMI was 31.6 kg/mē.

Among the key findings of the research:

  • The most common patient comorbidities were hypertension and diabetes.
  • Length of stay and direct medical costs were lowest for patients with BMI values in the normal to overweight range.
  • Every 5-unit increase in BMI beyond 30 kg/mē was associated with higher hospitalization costs: in 2010 U.S. dollars, approximately $250 to $300 for patients undergoing TKR and $600 to $650 for patients undergoing a revision joint replacement. These estimates persisted after adjusting for comorbidities and complications.
  • Every 5-unit increase in BMI beyond 30 kg/mē was associated with a mean hospital stay that was .11 days longer for patients undergoing primary TKR and .06 days longer for patients undergoing revision TKR. The data was the same for patients with and without comorbidities.

"The higher costs associated with obesity are believed to be largely due to managing comorbid medical conditions linked to obesity, such as diabetes," said lead study author Hilal Maradit-Kremers, MD, an associate professor of epidemiology at Mayo Clinic in Rochester, Minn. And yet in this study, "even in the absence of comorbidities, patients with obesity had longer stays and higher hospital costs."

"The bottom line is that obesity is increasingly common among patients undergoing joint replacement, which creates a myriad of technical and medical challenges, and likely contributes to the financial burden of the surgery," said senior author David G. Lewallen, MD, an orthopaedic surgeon, also from Mayo Clinic.


Story Source:

The above story is based on materials provided by American Academy of Orthopaedic Surgeons. Note: Materials may be edited for content and length.


Journal Reference:

  1. Hilal Maradit Kremers, Sue L. Visscher, Walter K. Kremers, James M. Naessens, David G. Lewallen. The Effect of Obesity on Direct Medical Costs in Total Knee Arthroplasty. The Journal of Bone and Joint Surgery (American), 2014; 96 (9): 718 DOI: 10.2106/JBJS.M.00819

Cite This Page:

American Academy of Orthopaedic Surgeons. "Obesity associated with longer hospital stays, higher costs in total knee replacement patients." ScienceDaily. ScienceDaily, 14 May 2014. <www.sciencedaily.com/releases/2014/05/140514153305.htm>.
American Academy of Orthopaedic Surgeons. (2014, May 14). Obesity associated with longer hospital stays, higher costs in total knee replacement patients. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/05/140514153305.htm
American Academy of Orthopaedic Surgeons. "Obesity associated with longer hospital stays, higher costs in total knee replacement patients." ScienceDaily. www.sciencedaily.com/releases/2014/05/140514153305.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins